MANDY NEWMAN: Open Payments
NPI 1710530019 · CENTRAL CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$129 in 7 payments from 5 companies in 2025. Trend: 2023 $139 · 2024 $109 · 2025 $129
Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Dexcom, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: UBRELVY, Ozempic, Dexcom G6 Transmitter, Rybelsus, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
